Company
Headquarters: Bergen, Norway
kr348.8 Million
NOK as of July 1, 2024
US$32.7 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a long term implantable micro sensor for monitoring glucose levels. The company was founded in 2006 and is headquartered in Bergen, Norway.